Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · IEX Real-Time Price · USD
0.145
-0.002 (-1.29%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Zomedica Market Cap
Zomedica has a market cap or net worth of $142.09 million as of July 2, 2024. Its market cap has decreased by -26.41% in one year.
Market Cap
142.09M
Enterprise Value
61.63M
1-Year Change
-26.41%
Ranking
Category
Stock Price
$0.15
Market Cap Chart
Since November 21, 2017, Zomedica's market cap has decreased from $213.40M to $142.09M, a decrease of -33.41%. That is a compound annual growth rate of -5.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 144.10M | -26.48% |
| Dec 29, 2023 | 196.00M | 22.73% |
| Dec 30, 2022 | 159.70M | -46.73% |
| Dec 31, 2021 | 299.80M | 130.08% |
| Dec 31, 2020 | 130.30M | 263.97% |
| Dec 31, 2019 | 35.80M | -69.30% |
| Dec 31, 2018 | 116.60M | -33.98% |
| Dec 29, 2017 | 176.60M | -17.24% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 147.40M |
| Caribou Biosciences | 146.31M |
| Stereotaxis | 145.66M |
| InfuSystem Holdings | 145.45M |
| MediWound | 145.15M |
| Galectin Therapeutics | 144.18M |
| Context Therapeutics | 143.25M |
| Rigel Pharmaceuticals | 142.75M |